Shopping Cart
Remove All
Your shopping cart is currently empty
Adebrelimab (SHR-1316) is a humanized monoclonal antibody targeting PD-L1 with antitumor activity for the study of solid tumors.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | In Stock | In Stock | |
| 5 mg | $645 | In Stock | In Stock | |
| 10 mg | $987 | - | In Stock | |
| 25 mg | $1,530 | - | In Stock | |
| 50 mg | $1,980 | - | In Stock | |
| 100 mg | $2,790 | - | In Stock |
| Description | Adebrelimab (SHR-1316) is a humanized monoclonal antibody targeting PD-L1 with antitumor activity for the study of solid tumors. |
| In vitro | Adebrelimab (0.06-1 mg/mL; treated for 48 hours) significantly inhibited the proliferation, migration, and invasion of SK-BR-3 and AU565 cells. [1] Adebrelimab (0.1-1 mg/mL; 48 hrs) decreased the expression of PD-L1, p-PI3K, and p-AKT, and increased the expression of FOXO1. [1] |
| In vivo | Adebrelimab (200 μg; administered 3 times per week for 21 days) showed significant inhibition of tumor growth. [1] |
| Synonyms | SHR-1316, SHR1316, HTI-1316, HTI1316, HTI-1088, HTI1088 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Host Species | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID |
| Cas No. | 2247114-85-6 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.